Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Marta Herreros Villanueva"'
Autor:
Marta Herreros-Villanueva, Luis Bujanda, Lourdes Ruiz-Rebollo, Rosana Torremocha, Ricardo Ramos, Rubén Martín, María Consuelo Artigas
Publikováno v:
Gastroenterología y Hepatología. 45:637-644
Pancreatic cancer remains one of the most devastating malignancies due to the absence of techniques for early diagnosis and the lack of target therapeutic options for advanced disease. Next Generation Sequencing (NGS) generates high throughput and va
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5ad9df1793917e403925b56583b0b77
https://doi.org/10.1016/j.gastrohep.2021.12.011
https://doi.org/10.1016/j.gastrohep.2021.12.011
Autor:
Agueda Iglesias-Gómez, María Francisco, Emma Martínez Moneo, Luis Bujanda, Marta García-Cougil, Mario Rodríguez-López, Lourdes Ruiz-Rebollo, E Iyo, Emilio Garabitos, Maider Martos, Mario Montes, Marta Herreros-Villanueva, Ibon Martínez-Arranz, Joaquín Cubiella, Enrique de Madaria
Publikováno v:
Molecular Biology Reports. 47:1583-1588
CA19-9 serum has been suggested as a marker of unresectability but different cut-off levels have been published. A cut-off of 500 U/ml is currently considered in an international consensus as biological criteria of borderline resectable pancreatic ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc22db34867bdb7914bf2c87c19619a1
https://doi.org/10.1007/s11033-020-05245-5
https://doi.org/10.1007/s11033-020-05245-5
Autor:
Chih-Chieh Chen, Tze-Kiong Er, Yen-Yi Liu, Jenn-Kang Hwang, Maria Jesus Barrio, Maximiliano Rodrigo, Enrique Garcia-Toro, Marta Herreros-Villanueva
Publikováno v:
PLoS ONE, Vol 8, Iss 2, p e55793 (2013)
The issue of whether patients diagnosed with metastatic colorectal cancer who harbor KRAS codon 13 mutations could benefit from the addition of anti-epidermal growth factor receptor therapy remains under debate. The aim of the current study was to pe
Externí odkaz:
https://doaj.org/article/1c8751741d0a4f27a8e1d25ea16e61ce
Autor:
Luis Bujanda, Cristina Sarasqueta, Angel Cosme, Elizabeth Hijona, José M Enríquez-Navascués, Carlos Placer, Eloisa Villarreal, Marta Herreros-Villanueva, María D Giraldez, Meritxell Gironella, Francesc Balaguer, Antoni Castells
Publikováno v:
PLoS ONE, Vol 8, Iss 1, p e51810 (2013)
BACKGROUND: Colorectal cancer (CRC) is the second most common cause of death from cancer in both men and women in the majority of developed countries. Molecular tests of blood could potentially provide this ideal screening tool. AIM: Our objective wa
Externí odkaz:
https://doaj.org/article/48ad09bada124e6abd0ac023f5fda14d
Publikováno v:
Clinica chimica acta; international journal of clinical chemistry. 493
Endometriosis is defined as the presence of ectopic endometrial tissue outside of the uterine cavity, most commonly in the ovaries and peritoneum. It is a complex disease that is influenced by multiple factors. It is also a common gynecological disor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3d9fc2ddda8d1089e8a7fa2ce076c73
https://pubmed.ncbi.nlm.nih.gov/30776361
https://pubmed.ncbi.nlm.nih.gov/30776361
Publikováno v:
Clinica Chimica Acta. 460:78-87
After decades of progress based on chemotherapy and targeted agents, patients with metastatic colorectal cancer still have low long-term survival, with more than 500,000 deaths occurring worldwide every year. Recent results showing clinical evidence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8273902fdb2601446daa91035cbc9652
https://doi.org/10.1016/j.cca.2016.06.027
https://doi.org/10.1016/j.cca.2016.06.027
Publikováno v:
Gastroenterología y Hepatología (English Edition). 40:675-677
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b73484cce62d33725bbe5e7470f6286
https://doi.org/10.1016/j.gastre.2017.11.002
https://doi.org/10.1016/j.gastre.2017.11.002
Autor:
Jose Manuel Mas, Marta Herreros-Villanueva, Ana Carmen Martín, Sergio Castillo, Rocio Arroyo, Rosa Pérez-Palacios, Teresa Sardon, Cristina Segu
Publikováno v:
Journal of Molecular Biomarkers & Diagnosis.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4a17980a651a47164fc689b27b03e0bd
https://doi.org/10.4172/2155-9929.1000398
https://doi.org/10.4172/2155-9929.1000398
Publikováno v:
Cancer Treatment Communications. 4:121-127
An important part of personalized medicine in colorectal cancer (CRC) relies on using the most effective treatment based on molecular biomarkers, which define groups of patients according to specific tumor alterations. Therefore, anti-tumoral drugs a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c960cd8b4ba3c84a6fd662a3b4729c1
https://doi.org/10.1016/j.ctrc.2015.08.003
https://doi.org/10.1016/j.ctrc.2015.08.003
Publikováno v:
Translational Cancer Research. 5:S335-S337
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::814786b30fe20d85ab2938177237e44b
https://doi.org/10.21037/tcr.2016.07.34
https://doi.org/10.21037/tcr.2016.07.34